Enabling the next generation of DNA synthesis using enzymes. You can also find us at @ansabio.bsky.social
San Francisco, CA
- Tweets 387
- Following 280
- Followers 1,373
- Likes 235
Ansa Biotechnologies retweeted
400 institutions served. Up to 50kb. 97% fulfillment. 42x increase in complexity. IDT+@AnsaBio is a partnership that pushes beyond the traditional 7kb synthesis ceiling, and resets standards. Get greater design freedom here: idtb.io/07t7jr
1
1
241
Case Study: hubs.li/Q04ydXv_0
The best-expressing antibody DNA is often what vendors call "complex."
With @AxioBiopharma, we tested 21 AI codon-optimized mAbs:
Vendor X: 11 rejected, 10 flagged complex
Ansa: 21/21 standard
In CHO: higher titers for 19/21, avg 1.9x
78
At Ansa, pushing the boundaries of DNA synthesis goes hand in hand with responsible innovation.
Our SVP of Informatics, Scott Fay, spoke to @GenomeWeb about the industry’s responsibility to advance #AI & #DNAsynthesis technologies safely.
hubs.li/Q04y8q8w0
#biosecurity
62
"Hard to synthesize" is almost never a synthesis problem.
Repeats, GC extremes, and homopolymers each fail at particular steps of a DNA manufacturing workflow — and not at the others.
Learn what makes DNA sequences hard to synthesize in our new article: hubs.li/Q04xGdpb0
93
📣 We’re proud to partner with Waterfall Scientific on ESCALATOR, an ARPA-H GIVE project advancing on-demand production of high-purity mRNA therapeutics and vaccines.
Read more: hubs.li/Q04wp1N70
1
112
We’re expanding our partnership with @idtdna to make ambitious designs easier to turn into research-ready DNA.
Now: feasibility, pricing & turnaround before checkout for constructs up to 50 kb.
400+ institutions. 33 countries. 97% fulfillment.
👉 hubs.ly/Q04w3pG30
1
2
188
In June, 96% of Ansa orders shipped on time or early.
𝗧𝗵𝗲 𝗼𝘁𝗵𝗲𝗿 𝟰% 𝗦𝗵𝗶𝗽𝗽𝗲𝗱 𝗳𝗿𝗲𝗲.
That's the Ansa On-Time Guarantee: miss the date, you don't pay.
𝟵𝟵.𝟴% 𝗼𝗳 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 𝘄𝗲𝗿𝗲 𝗳𝘂𝗹𝗳𝗶𝗹𝗹𝗲𝗱.
See how it works: hubs.li/Q04tJT5z0
1
110
💡 Fun Fact Friday: We went from 600 bp → 50 kb in just 15 months.
The bigger story? Expanding what researchers can design, build, and explore.
More design freedom. More possibilities. More room to push science forward.
What will you build with 50 kb? hubs.li/Q04t4hp20
2
100
Today’s AI models can predict expression, optimize sequences, design CRISPR guides, and generate entirely new proteins and DNA sequences. The challenge is turning those digital designs into physical constructs that can actually be tested.
Let's dive in!
hubs.li/Q04sPdvK0
95
🧬 AI can now design mRNA sequences no one would've thought to try. The catch? Some of them are nearly impossible to actually build.
Our CSO & Co-founder, @dan161803 spoke with @biocompare about this gap between AI-designed and AI-buildable.
👉 hubs.li/Q04r_45V0
1
77
Synthetic DNA companies don't usually ask to be regulated. We're doing it anyway.
In a new op-ed for @TheScientistLLC , our CEO @Jason_Gammack argues that the current biosecurity screening honor system isn't enough.
Read the full piece here: hubs.li/Q04r1-9G0
1
81
🧬 𝗬𝗼𝘂 𝗮𝘀𝗸𝗲𝗱, 𝘄𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗲𝗱! By popular request, we're extending our iGEM Competition program submission window for 𝘁𝘄𝗼 𝗺𝗼𝗿𝗲 𝘄𝗲𝗲𝗸𝘀 — now closing 𝗝𝘂𝗹𝘆 𝟯𝟭𝘀𝘁.
Don't miss this extended window — submit today!
👉 ansabio.com/igem
Calling all #iGEM2026 teams🧬
Ansa is giving 20 teams up to 20 kb of free clonal DNA, including complex sequences that other vendors just can't make.
Submit by June 30. Selected teams notified on a rolling basis.
Apply! 👉 ansabio.com/igem
#iGEM2026 #FreeDNA #SynBio
106
🔎 DNA synthesis biosecurity runs largely on the honor system today. As generative AI lowers the barrier to designing harmful biological agents, that's no longer good enough. Ansa's VP of Informatics, Scott Fay, shares his perspective on what's needed.
hubs.li/Q04pvwxM0
119
𝗛𝗲𝗹𝗽𝗶𝗻𝗴 𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗸𝗲𝗲𝗽 𝗽𝗮𝗰𝗲 𝘄𝗶𝘁𝗵 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: Take a peek inside the partnership with @idtdna in this article by Christopher Vakulskas, who truly put us through our paces.
bit.ly/3R1cECC
1
1
144
We built Ansa on the belief that DNA synthesis shouldn't be the bottleneck in biological research.
What's the hardest sequence you've tried to synthesize? Drop it in the comments — we love a good challenge 💪 .
90
👀 A partnership worth watching: Decades of trusted distribution meets a breakthrough in DNA synthesis.
✨IDT’s trusted expertise 🤝 @AnsaBio’s enzymatic DNA synthesis platform✨
Push boundaries with longer DNA constructs, up to 50kb, challenging motifs, and higher complexity backed by a partner trusted for consistency and accuracy. Together, we empower researchers to confidently tackle their most complex projects.
Learn more here: idtb.io/07t7jr
1
3
271
32 Cas9 gRNAs cloned in a single reaction. And arrays that once took 3-4 months, delivered in <7 days.
Thanks @danielito2129 for sharing how Ansa helped transform your tomato research.
🧬 Ready for your tools to move at the speed of your ideas? hubs.li/Q04nNQG20
2
145
"For the first time in my career, synthesis is no longer the bottleneck in my science."
Thanks to Colin Harvey, Co-founder & VP of Early Discovery at @hexagonbio for sharing his experience.
We built Ansa differently, to serve scientists the constructs they need, on time.
2
1
1
103
Ansa Biotechnologies retweeted
Unlock new insights in antibody expression. Watch our on-demand GEN webinar with Justin Byers and Daniel Lin-Arlow, PhD, on benchmarking gene design and codon optimization. hubs.li/Q04jc_jc0 @AnsaBio #Antibodies #DNA #Biotech
1
3
1
418